Dr Marjan Wouthuyzen-Bakker, University Medical Center Groningen
Marjan Wouthuyzen-Bakker is an infectious disease specialist working at the University Medical Center Groningen, the Netherlands. Her research field involves implant related infections; in particular periprosthetic joint infections and vascular graft infections. She is the past-president of the ESCMID study group of implant associated infections (ESGIAI) and the current vice-president of the European Bone and Joint Infection Society (EBJIS). She has a leading role in many PJI networks, like the Northern Infection Network on Joint Arthroplasty (NINJA) and the Orthopaedics Device Infection Network (ODIN).
Dr. Carlos Higuera-Rueda, is currently a staff surgeon at the Cleveland Clinic Florida, where he divides his time between leadership, research, and patient care. He is the Director of the Levitetz Department of Orthopaedic Surgery and Director of Research of the Integrated Surgical Institute at Cleveland Clinic Florida. He currently holds the Amy and David Krohn Family Distinguish Chair in Orthopaedic Outcomes. Dr. Higuera completed his residency at the Cleveland Clinic and a clinical fellowship at Thomas Jefferson University Hospital
Dr Andrew Fraval, is a Melbourne-based orthopaedic surgeon specialising in hip and knee arthroplasty. He works at Melbourne Orthopaedic Group and St Vincent’s Hospital Melbourne and his practice encompasses the full spectrum of hip and knee arthroplasty presentations. He completed an International Adult Reconstruction Fellowship at the Rothman Orthopaedic Institute in Philadelphia and is actively involved in research in infection prevention, primary hip and knee arthroplasty, periprosthetic joint infection, revision arthroplasty and registry-based outcomes.
A/Prof David Dewar is a Newcastle-based Orthopaedic Surgeon specializing in hip and knee replacement, joint preservation, and complex trauma. He holds public and private appointments at John Hunter Hospital and Lake Macquarie Private Hospital, and consults at the Newcastle Orthopaedic Group in Cooks Hill. After completing his orthopaedic training in New South Wales, A/Prof Dewar pursued advanced subspecialty fellowship training in Sydney (Hip & Knee Surgery) and at the Hospital for Special Surgery in New York (Complex Trauma).
A/Prof. Chris Jones is a fellowship-trained orthopaedic surgeon with subspecialty expertise in hip and knee arthroplasty and complex trauma. His clinical practice includes primary and revision hip and knee replacement, computer-assisted and robot-assisted arthroplasty, unicompartment knee replacement, ceramic hip resurfacing, prosthetic joint infection management, and trauma surgery. He is committed to tailoring treatment to each patient’s anatomy, lifestyle, and goals, with a focus on returning people to work, family life, and sport.
Dr Kelly Cairns is the Lead Antimicrobial Stewardship (AMS) pharmacist at The Alfred Hospital, Melbourne, Australia, and is currently undertaking a PhD through the Department of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia. She has worked in infectious diseases and AMS for 20 years, leading initiatives locally, nationally and internationally. She has an interest in optimising antimicrobial utilisation to both improve patient outcomes and minimise antimicrobial resistance.
Dr Laurens Manning is an infectious diseases physician and researcher based in Perth. He has a diverse set of research portfolios that include antimicrobial pharmacology, rheumatic heart disease, malaria, tropical paediatrics, diabetic foot disease, cellulitis and peri-prosthetic joint infections.
Dr Catherine Hibberd is an Australian-trained Orthopaedic Surgeon with a subspecialty interest in hip and knee arthroplasty. She completed her undergraduate medical degree and Master of Surgery at the University of Melbourne before undertaking Orthopaedic training in Sydney. Following fellowship training in Hip and Knee Arthroplasty and Lower Extremity Reconstruction at St Michael's Hospital, Toronto, she returned to Australia. Dr Hibberd has authored multiple peer-reviewed publications and presented research at national and international scientific meetings. She also holds a Master of Surgical Education and is Director of Training for Orthopaedic Surgery at St George and Sutherland Hospitals.
Dr Kelly Cairns is the Lead Antimicrobial Stewardship (AMS) pharmacist at The Alfred Hospital, Melbourne, Australia, and is currently undertaking a PhD through the Department of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia. She has worked in infectious diseases and AMS for 20 years, leading initiatives locally, nationally and internationally. She has an interest in optimising antimicrobial utilisation to both improve patient outcomes and minimise antimicrobial resistance.
Prof Anton Peleg is a Professor of Infectious Diseases and Microbiology, Director of the Department of Infectious Diseases at The Alfred Hospital and Monash University, Director of the Centre to Impact Antimicrobial Resistance (AMR), Monash University, and Theme Leader for Infection and Immunity at the Monash Academic Health Research and Translational Centre. He has also recently been elected as a Fellow of the Australian Academy of Health and Medical Sciences.
Dr Alison Boast is a Paediatric Infectious Diseases Physician completing additional training in Clinical Pharmacology, alongside a PhD focused on optimising the treatment of invasive infections in children using pharmacometrics. Together with A/Prof Amanda Gwee she is leading the ASID-endorsed BEST trial of oral versus intravenous antibiotics for the treatment of paediatric bone and joint infections.
Katharina Wolf is a biomedical scientist and third-year PhD candidate at the University of Otago, Christchurch, where she is a member of the Infection Group. Her research focuses on the development of non-invasive diagnostic tests for infectious diseases, with a particular interest in paediatric bone and joint infections. Her PhD investigates the use of pathogen-derived cell-free DNA as a novel diagnostic tool to improve the rapid detection and diagnosis of these infections in children.
Dr Keerthi Anpalagan is a postdoctoral researcher at The Kids Research Institute Australia, based at Perth Children’s Hospital. She is a member of the multidisciplinary SNAP (Staphylococcus aureus Network Adaptive Platform) clinical trial team, and her PhD research focused on understanding the economic burden of paediatric S. aureus bacteraemia (SAB), optimising antibiotic treatment, and improving diagnostic imaging strategies for children with SAB.
Dr Shu Ki Tsoi is a Melbourne-based paediatric infectious diseases specialist and general paediatrician. She trained in Melbourne and Darwin and is an Honorary Research Fellow with the Tropical Diseases Group at the Murdoch Children’s Research Institute. Her research focuses on Streptococcus pyogenes, and she will commence a PhD with the group in 2027.
Dr Rebecca Ward is a dual-trained paediatrician and infectious diseases physician who completed her fellowship at Queensland Children’s Hospital, Brisbane. She currently works as an Infectious Diseases Research Fellow and will continue her research journey with the HeIDI team from June. Her clinical interests include in infections in immunocompromised children, bone and joint infections, and hospital-acquired infections.
Professor Josh Davis is an infectious diseases physician at the John Hunter Hospital in Newcastle, NSW, Australia. He is also a Professor of Infectious Diseases at the University of Newcastle and director of the Infection Research Program at the Hunter Medical Research Institute. He is a clinical trialist with expertise in Bayesian adaptive platform trials, several of which he currently leads. These include the ROADMAP trial, which we co-leads with Prof Laurens Manning.
A/Prof Sina Babazadeh is a Melbourne based orthopaedic surgeon specialising in hip, knee and wrist surgery, with appointments at St Vincent's Hospital Melbourne, Eastern Health and the University of Melbourne. He is the Chair of the Orthopaedic Devices Infection Network (ODIN), an international collaboration dedicated to advancing the prevention, diagnosis and treatment of prosthetic joint infection (PJI).
Dr David Campbell is a joint reconstruction surgeon at the Wakefield Orthopaedic Clinic, Adelaide. Clinical Academic and Head of Department of Orthopaedics and Trauma, The Queen Elizabeth Hospital. He is part of the PJI network of studies including PIANO and ROADMAP. His goals are to facilitate PJI networks including a national PJI registry. David is married with three adult children. He enjoys water and snow skiing; he is a competition aerobatic pilot which does not please his wife!
Professor Trisha Peel is a L1 NHMRC Fellow and a recognised leader in infectious diseases research. Based at Monash University and Alfred Health, she is appointed as Deputy Director in the Department of Infectious Diseases. Her work focuses on preventing and managing infections in patients undergoing surgery, leading large studies that have improved outcomes for patients. She collaborates with a broad range of experts, including surgeons, anaesthetists, and consumers, to ensure her research addresses real-world needs. Her findings have been published in top journals, such as the New England Journal of Medicine, and she has received multiple awards, including the 2024 ACTA Trial of the Year, for her contributions to better patient care.
Prof Minoo Patel is an orthopaedic surgeon based at Epworth and Cabrini Health. He specialises in trauma and limb lengthening and reconstruction surgery with a special interest in limb deformities, non-unions and infected fractures and non-unions. He completed a Limb Reconstruction fellowship at the pioneering Maryland Centre for Limb Reconstruction, Baltimore under Dror Paley and John Herzenberg. He also specialises in shoulder and elbow surgery with a special interest in peri-prosthetic fracture reconstruction. He completed an AO Fellowship at Massachusetts General Hospital, Boston. He is the secretary of the Australian Orthopaedic Trauma society, and present-elect for 2027-28.
Dr Stefano Giulieri is a clinician researcher with a special interest in staphylococcal genomics and orthopaedic infections. He is passionate about using evolutionary biology and statistical genomics to answer clinical questions in infectious diseases. He is particularly interested in how bacteria like the hospital superbug Staphylococcus aureus evolve within patients during severe infections to evade both antibiotics and immune responses. He is an Infectious Diseases Physician at the Royal Melbourne Hospital where he leads the orthopaedics infections liaison program. Before moving to Melbourne, he was the Head of the Infectious Diseases Consultation in the Orthopaedics Department at the Lausanne University Hospital, Switzerland. is a clinician researcher with a special interest in staphylococcal genomics and orthopaedic infections. He is passionate about using evolutionary biology and statistical genomics to answer clinical questions in infectious diseases. He is particularly interested in how bacteria like the hospital superbug Staphylococcus aureus evolve within patients during severe infections to evade both antibiotics and immune responses. He is an Infectious Diseases Physician at the Royal Melbourne Hospital where he leads the orthopaedics infections liaison program. Before moving to Melbourne, he was the Head of the Infectious Diseases Consultation in the Orthopaedics Department at the Lausanne University Hospital, Switzerland.
AUSTRALASIAN SOCIETY FOR INFECTIOUS DISEASESABN 20 108 151 093
ACN 155 632 698
PO BOX Q379 QVB SYDNEY 1230
Email: events@asid.net.au |
ASID acknowledges the Aboriginal and Torres Strait Islander peoples as Traditional Owners, Custodians and First Nations of Australia, and Māori as tangata whenua and Treaty of Waitangi partners in Aotearoa New Zealand.